AmeriTerpenes, which operates production facilities across Florida and Georgia, produces the biomolecules essential for scent and flavor applications. Symrise leadership stated that the move follows a months-long operational carve-out designed to prepare the unit for independent development. Chief Executive Jean-Yves Parisot framed the transaction as a strategic effort to sharpen the firm’s competitive profile.
In section Market Quotes
Symrise Offloads U.S. Terpene Unit to Mutares in Portfolio Shift
A mid-double-digit million euro impairment awaits Symrise as the German fragrance and flavor giant divests its American terpene business to private-equity firm Mutares. The deal, aimed at refining the company’s core focus, includes long-term supply contracts that keep the two entities commercially linked despite the change in ownership.
While the specific purchase price remains confidential, the financial impact of the sale will appear in the company’s 2026 books. The resulting impairment reflects the adjustment of the asset's value as it transitions under the control of Mutares. Existing commercial agreements ensure that Symrise retains access to the terpene-based raw materials produced by the divested business, maintaining continuity for its food and cosmetics clients.
Comments (0)
No comments yet. Be the first!